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In a  recent paper  (1) we demonstrated that interaction of highly purified human 
Cq esterase with rat or guinea pig serum results in generation of an activity identical 
to anaphylatoxin by available criteria. The formation of this activity by C'I esterase 
required  the presence of serum constituents with  the same heat lability as comple- 
ment, was blocked by chelation of Mg  2+, was partially inhibited  by salicylaldoxime 
or phlorizin, and was associated with essentially complete depletion of hemolytic com- 
plement activity. On the basis of these and related earlier studies (2, 3), we postulated 
(1) that C'1 esterase initiates formation of anaphylatoxin through reactions involving 
at least C~4, C'2, and C'3, possibly emerging as a reaction product at or shortly beyond 
the C'3 step.  1 
We have submitted  this hypothesis to direct  investigation,  examining reac- 
tion  mixtures  containing various  purified  components  of  human  complement 
for the presence  of anaphylatoxin  activity.  It is our purpose in this  paper  to 
report successful generation of anaphylatoxin by interaction in free solution of 
purified  C/1  esterase,  C~4, C'2,  and  C~3. The  properties  oi  such  mixtures  in 
contracting and desensitizing smooth muscle, enhancing vascular permeability, 
degranulating  mast cells in guinea pig mesentery preparations,  and liberating 
histamine from isolated rat peritoneal mast cells will be described. The mecha- 
nism of formation of anaphylatoxin and its separation from complement  com- 
ponents  will be reported  separately.  A  preliminary communication  describing 
some of our observations  has  appeared  previously (4). 
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1 The complement system, as presented and discussed in this paper,  comprises 11 serum 
proteins.  CJ1 is a macromolecular complex of three proteins, C'lq, C'lr, and C'ls. The enzy- 
matically active subunit derived from C'ls is referred to as C'I esterase. Subsequently acting 
components,  in  the  order  of their  reaction,  are  C'4, C'2, C'3, C'5, Cr6, C'7, C'8, and  C'9. 
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Materials  and Methods 
Preparation and Assay of Human Complement Components 
Serum.--Blood was  collected  without  anticoagulant  from  apparently  healthy  human 
donors and allowed to clot at room temperature for 1-2 hr and at 2°C for several additional~ 
hours or overnight. Serum was separated by centrifugafion at 2°C. Pools of serum from 2-25 
donors were either used immediately or stored at  -60°C. 
C'1 esterase.--This enzyme, derived from the first component  of complement, was pre- 
pared and assayed according to Haines and Lepow (5). Because of the presence of immuno- 
logically detectable C'5 in some preparations and the known migration of C'I esterase as an 
a-globulin  (5),  the final product was subjected to preparative electrophoresis in a  Pevikon 
block (6). The separation was carried out at 2°C in barbital buffer,  pH 8.6, #  =  0.05  for 18 
hr employing a potential gradient of 2.5 v per era. The resulting product had a specific activity 
of 440  units per optical density unit at 280 m#,  as assayed with N-acetyi-L-tyrosine ethyl 
ester as substrate, and was free of detectable C'3, C'4, and C'5 in micro-double diffusion  tests 
in agar employing antisera  specific for these purified components.  It was stored at  -60°C 
at a concentration of 100 units per ml in phosphate-buffcred saline, pH 7.4. 
Ct4.--Preparations of C'4 were either kindly donated by Dr. H. J. Mttller-Eberhard (desig- 
nated M-E) or prepared in this laboratory (designated WRU) by modifications of the method 
of Mfiller-Eberhard and Biro (7). The well-known variability and empirical behavior of dif- 
ferent commercial batches  of TEAE- or DEAE-cellulose necessitated  the changes made in 
the procedure. Best results were obtained with columns of DEAE-celinlose, 1.05 meq per g, 
type 20. A pseudoglobulin fraction of serum, prepared as described by Miiller-Eberhard and 
Biro, was applied at equilibration conditions of pH 7.3 sodium phosphate,/z  =  0.04. The col- 
umn was then washed exhaustively with pH 7.3 phosphate buffer,/x =  0.04, containing 0.13 
NaCI (starting buffer). C'4 was eluted with a linear NaC1 gradient, beginning with starting 
buffer and  reaching a  limit of 1.5 M NaCI. C'4 activity, assayed essentially as reported by 
Mtiller-Eberhard  and  Biro,  emerged with the main protein peak  at  about/z =  0.5  NaCI. 
Nearly all of the original hemolytic activity of C'4 was contained in about 200 mg protein 
per 100 ml of serum. This material was concentrated by ultrafiltration to 15-20 mg of protein 
per ml and dialyzed against second cycle starting buffer: pH 7.9 sodium-potassium phosphate, 
conductance at 23°C of 7 mmho/cm. It was then applied to a similarly equilibrated column 
of hydroxylapatite (Bio-Gel HTP, Bio-Rad Laboratories, Richmond, Calif.), employing about 
30 g of hydroxylapatite for 200 mg of protein. Mter exhaustive washing with equilibration 
buffer, step-wise elution was performed with pH 7.9 sodium-potassium phosphate buffers of 
conductance 11 and 13 mmho/cm. C'4 activity emerged at 13 mmho/cm without a detectable 
protein peak, as measured by absorption at 280 nag, in a volume of 700-900 ml. Mter concen- 
tration by ultrafiltration, further separation was achieved by preparative electrophoresis in a 
Pevikon block (6, 7). The final material contained 3-4 mg of protein per 100 ml of original 
serum and at least 25% of the original hemolytic activity of C'4. In micro--double  diffusion 
tests  or immunoelectrophoresis in  agar,  a  single  line was  obtained  with antisera  to whole 
human serum or to purified C'4. C'3 or C'5 could not be detected with specific antisera to these 
components.  Although most of the protein migrated as a  dense band  of/~-globulin in disc 
electrophoresis, slightly faster and slower protein species were observed. The preparation was 
either used fresh or stored at -60°C in 50% glycerol. 
C'2.--This protein  was  prepared  by  modifications of  a  method  previously reported  in 
preliminary form from  this  laboratory  (8).  Unusual  difficulties  have been  encountered  in 
obtaining adequate quantities of pure, hemolytically active C'2 and highly enriched prepara- 
tions have therefore been used in the present study. These were purified in the range of 500- 
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conversion d  the intermediate complex EAC'I, 4 to EAC'I, 4, 2 according to procedures de- 
vised by Leon and described elsewhere  (9). C'3, C'4, and C'5 were not detectable by micro- 
double diffusion tests in agar but several bands were observed in disc electrophoresis. Fractions 
were either used fresh or stored at --60°C either in the presence or absence of 50% glycerol 
C'3.--Preparations of C'3 were either kindly donated by Dr. H. J. Mtiller-Eberhard (desig- 
nated M-E) or prepared in this laboratory (designated WRU) by a convenient modification 
of the method of Nilsson and Miiller-Eberhard (10).  In the fractionation of C'lq, C'lr, and 
C'ls, a protein peak highly enriched in C'3 emerges from the column of DEAE-cellulose after 
C'lq and before C'lr (11). Employment of this fraction for further chromatography on hy- 
droxylapatite (10) makes possible simultaneous preparation of four factors of the complement 
system. Furthermore, by using a shallower gradient than originally described (11), substitut- 
ing a limit buffer containing 0.35 ~  rather than 0.5 M NaC1, significantly less contamination 
with flirt-globulin  (10)  has  been  observed  from  DEAF_,-cellulose chromatography.  Indeed, 
immunoelectrophoretically pure tim-globulin appears  in the chromatogram as a  small peak 
immediately preceding the larger peak containing C'3. Commercial hydroxyiapatite (Bio-Gel 
HTP, Bio-Rad Laboratories) has proven highly effective for final separation. By these means, 
10-15 mg of C'3 per 100 ml of serum may be routinely obtained as a single protein species in 
disc electrophoresis and immunoelectrophoresis or micro--double  diffusion  in agar using anti- 
sera to whole human serum. No observable conversion of C'3 to immunoelectrophoretically 
faster forms of this protein  (12)  occurred during preparation.  C'4 and  C'5 could not be de- 
tected in micro-double diffusion tests with antisera to these purified components. The final 
product was either used fresh or stored at --60°C in 50% glycerol (13). 
C'5.--A  single preparation  of highly purified C'S (10) was kindly donated  by Dr. H. J. 
Miillcr-Ebethard. 
Immunological Reagents and Procedures 
Ant/sera.--Rabbit and horse antisem to whole human serum were obtained commercially 
(Behringewerke,  Marburg-Lahr,  West  Germany).  Rabbit  antisera  to  C'3  and  C'4  were 
raised in rabbits by Dr. J. Boyer, using highly purified components originally donated by Dr. 
H. J. Miiller-Eberhard or prepared in this laboratory. Rabbit antiserum to C'5 (10) was sup- 
plied by Dr. I-I. J. M0ller-Ebcrhard. 
Immunodectrophoresis.--Immunoelectrophoretic analyses  were  performed  by  the micro- 
method of Scheidegger (14) employing a potential gradient of 9 v per cm for 70 rain. 
Double Diffusion in Agar.--A microprocedure using glass microscope slides covered with a 
gel of 1% agar was employed. Wells were punched with a  commercial template  (LKB-Pro- 
duktcr,  Stockholm, Sweden). The general technique has been described by Crowle  (15). 
Chemicals and Chemical Methods 
Triethanolaraine~Buffered Saline (TBS).--This buffer, at pH 7.4 and ionic strength  0.15, 
was used as diluent in all hemolytic assays  (16). For reactions preceding the C'3 step of im- 
mtme hemolysis, it contained 1.5 ×  10  "-4 M Ca  2+ and 5 ×  10  "~ x~ Mg2+; for subsequent  reac- 
tions, it contained 8 X  10  -8 ~  NasHEDTA. 
Phosphate~Buffered Saline (PBS-M~+).--Tlfis  buffer, at pH 7.4 and  ionic strength 0.15, 
was used as diluent in all biological systems to be described. It was composed  of 0.135 
sodium chloride, 0.015 # sodium phosphate, and 5 X  10  -~ u  Mg  2+. 
Salts  of  Ethylenediaminetetraa~etic Acid  (EDTA).--Reagent  grade  NavH2EDTA  was 
titrated  to pI-I 7.4 at a  stock concentration of 0.15  ~t, giving a  solution largely in the form 
NazHEDTA. Na2MgEDTA  (Geigy Chemical Corp.,  Ardsiey, N.  Y.)  was  titrated  to pFI 
7.4 at a stock concentration of 0.15 u. 
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from hydroxylapatite were prepared at stated values of specific conductance at 23°C  (10). 
This was  measured with a  commercial conductivity meter  (Radiometer  Co.,  Copenhagen, 
Denmark). 
Disc Electrophoresis.--This technique was performed with a commercial apparatus (Model 
6,  Canal Industrial Corp.,  Bethesda,  Md.)  according to directions supplied by  the  manu- 
facturer. 
ProtOn Determinations.--Protein concentrations were either measured by the  method of 
Lowry and coworkers (17)  or estimated by absorption at 280 m#, assuming a value for E~% 
of 10. 
Biological Materials and Procedures 
Histaminc.--Histamine  dihydrochloride  (Nutritional  Biochemicals  Corp.,  Cleveland, 
Ohio) was dissolved in Tyrode's solution at a  stock concentration of 1/zg of histamine base 
per ml for contraction of isolated smooth muscle. For experiments on enhanced vascular per- 
meability, stated concentrations in PBS-Mg  ~+ buffer were used. 
Bradykinin.--The  synthetic product,  kindly donated  by  Sandoz,  Inc., Hanover,  N.  J., 
contained 80 #g per ml. It was diluted further in appropriate buffers, as for histamine. 
Triprolidinc.--Triprolidine  hydrochloride (Actidil, Burroughs Wellcome and  Co.,  Tucka- 
hoe, N. Y.) was dissolved in Tyrode's solution at a  stock concentration of 0.1 #g per ml for 
use as an antihistamine with smooth muscle preparations. For experiments on enhanced vascu- 
lar permeability, it was incorporated with the intravenous dose of Pontamine Sky Blue such 
that a  dose of 0.1  mg per kg was administered. 
Pontamine Sky Blue.--Pontamine  Sky Blue 6x (E. I. du Pont de Nemours and Co., Inc., 
Wilmington, Del.) was dissolved in 0.075 ~a NaCI at a  concentration of 5%. 
Contraction of Smooth Muscle Preparations.--Assay  of  anaphylatoxin activity was  per- 
formed routinely on isolated guinea pig ileum, as described previously (1). Segments of ileum 
were suspended in a 5 ml organ bath containing atropinized Tyrode's solution (10 #g atropine 
sulfate per liter) and maintained at 37°C with constant aeration. Mter establishing constant 
reactivity to several additions of 0.05 #g of histamine, a  stated volume of test sample was 
added and allowed in contact for 30 sec. The preparation was then washed with fresh Tyrode's 
solution, retested with 0.05 #g of histamine, and washed again with fresh Tyrode's solution. 
Successive test samples were assayed in this manner, always allowing an interval of  1 rain 
for equilibration of the ileum in fresh Tyrode's solution before adding either histamine or test 
sample.  Contractions were  recorded  on a  kymograph supplied  with electroscnsitive paper, 
employing  an  electrically  stimulated  lever arm  attached  to  the  ileum  by  nonconducting 
thread. The amplitude of contractions was measured as the perpendicular distance from the 
base line, uncorrected for magnification by the lever (circa 5x). In order to eliminate the effect 
of desensitization (tachyphylaxis), only one test sample was assayed with each segment of 
guinea pig ileum. In the few cases in which rat uterus was used for additional tests, Tyrode's 
solution was replaced by de Jalon's solution and the temperature was reduced to 31°C.  For 
this purpose, either Wistar or Sprague Dawley female rats were injected subcutaneously with 
10 #g of stilbesterol (Eli Lilly and Co., Indianapolis, Ind.) 36 hr prior to sacrifice. The induc- 
tion of early estrus was confirmed by examination of vaginal smears. 
Enhancement of Vascular Permeability.--This  property of anaphylatoxin was tested using 
the technique of Miles and Wilhelm (18). Noninbred albino guinea pigs of either sex, usually 
weighing between 400 and 450 g, were depilated and injected intravenously with 1.2 ml per 
kg of body weight of a 5% solution of Pontamine Sky Blue 6x. The solutions to be tested were 
then injected intracutaneously into the dorsum of the guinea pig in a volume of 0.1 ml, using 
No. 26, ~  inch steel hypodermic needles and plastic tuberculin syringes. 15 min after the last 
injection, the size of the lesion was estimated by averaging the widest diameter and the diam- 
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Degranulation of Mast Cells in Guinea Pig Mesentery.--Fragments  of guinea pig mesentery 
about 1 X  1 cm were shaken at 37°C for 15 rain with 0.7 ml of the solutions to be tested and 
0.1 ml of 1% glucose. The tissue was transferred to fixative and then stained with 0.1% tolui- 
dine blue at acid pH, as described by Mota and Dlas da Silva (19). Mast cell damage was 
quantified by counting the number of cells containing metachromatic granules in 20 micro- 
scopic fields (magnification of  100)  and calculating the average number per field. 
Rdease of Histamine from Isolated Rat Peritoneal Mast Cdls.--The ability of anaphylatoxiu 
to release histamine from suspensions of rat peritoneal cells was tested by modification of 
the method of Dins da Silva and Fernandes (20). Suspensions of rat peritoneal cells containing 
about 5% mast cells were obtained by injecting 15 ml of PBS-Mg  *+ buffer containing 5 #g 
per ml of heparin and 0.1%  gelatin into the peritoneal cavity of 200-g Wistar or  Sprague 
Dawley rats of either sex, which had previously been anesthetized with ether and exsangui- 
nated by decapitation. The abdominal wall was gently massaged for 1 rain and then incised 
along the midventrai line. Fluid in the peritoneum was withdrawn with a 5 ml syringe without 
needle and transferred to plastic tubes at room temperature. The cells were sedimented by 
centrifugation for 5 rain at 50 g and washed twice with the same buffer used for peritoneal 
injection. The cell yield from three rats was suspended in about 1 ml of the same buffer and 
held at room temperature for use within 30 rain. 
Assay mixtures were composed of 0.8 ml of test solution or PBS-Mg  2+ buffer, 0.1  ml of 
1% glucose and 0.1 ml of cell suspension. After incubation at 37°C for 10 rain, the cells were 
sedimented by centrifugation for 3 rain at 400 g. The supernatant fluids were carefully decanted, 
1 drop of  1% phenol red was added, and the solution acidified with 2 drops of 0.1 ~  HC1. 
The sedimented cells were resuspended in 1 ml of PBS-Mg  2+ buffer and acidified in the same 
manner. All samples were placed in a boiling water bath for 30 rain. Neutralization with 0.1 N 
NaOH was performed just prior to assay. 
Histamine content of each supernatant and sedimented sample was assayed on guinea pig 
ileum,  according to  Feldberg and Talesnik (21). The results were expressed as per cent of 
total histamine liberated into the fluid phase. 
Preparation of Rat and Guinea Pig Anaphylatoxin.--For  experiments on cross-desensitiza- 
tion of guinea pig ileum by anaphylatoxins derived from different species, rat and guinea pig 
anaphylatoxin were prepared by incubation of the corresponding plasmas with agar suspen- 
sion or human C'I esterase, as described previously (1). Plasma was obtained either by draw- 
ing blood into heparin (50/zg per ml) or Na2MgEDTA (5 X  10  -a x0. 
General Experimental Design 
Aliquots of purified preparations of C'2, C'3, and C'4 which had been frozen were thawed 
and  dialyzed  exhaustively with stirring against PBS-Mg  2+ buffer at  2°C.  C'I  esterase was 
thawed as needed and used without further treatment. These components usually maintained 
good activity in the liquid state for about 1 wk. No relevant differences were observed in the 
behavior of  purified  components which had been frozen or used  shortly after preparation 
without prior freezing. 
On the basis of preliminary trials, the following general procedure was adopted for experi- 
ments with purified components of complement. Mixtures of C'2, C'3, and C'4 and an afiquot 
of  C'I  esterase, all at desired concentrations in PBS-Mg  2+ buffer, were preincubated sepa- 
rately at 37°C for 2 mill. The enzyme was then added and incubation continued for an addi- 
tional stated period, most frequently 5 mill. The reaction mixture was chilled in an ice bath 
and either tested at once or acidified with N HCI or pH 3.0 glycine buffer, 0.1 ~  to adjust to 
pH 3.5--4.0. As will be reported separately, human anxphylatoxin is more stable at acid pH 
than in neutral solutions. 
In the experiments reported here, all possible control mixtures lacking a single component 
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ing three reactants were identical to those in the complete system, volume being adjusted 
with PBS-Mg  2+ buffer. 
In a few experiments, C'5 was also added to the reaction mixture. In these cases, all com- 
ponents other than CI1 esterase  were preincubated at 37°C for 2 min prior to addition of pre- 
warmed enzyme. The general procedure and inclusion of controls were otherwise as already 
described. 
RESULTS 
Generation of Anapkylatoxin from Purified Components of Human Complement 
and Its Activity on Smooth Muscle Preparations 
Contraction of Guinea Pig Ileum by Reaction Mixtures Containing C'I esterase, 
CP4, C'2, and C'3.--The following is representative of a large number of experi- 
ments performed over a period of more than 1 yr with many different batches 
of purified components. In the cases of C'3 and C'4, preparations either donated 
by Dr.  H.  J.  Mtiller-Eberhard  (M-E)  or purified in  this  laboratory (WRU) 
were employed with entirely comparable results. 
A reaction mixture containing C'I esterase, C'4, Ct2, and C'3 was incubated 
at 37°C for 5 rain and chilled in ice for immediate testing, as described under 
General Experimental Design.  The final concentrations of reactants  were: 5 
units per ml of C'1 esterase, 50 #g per ml of C'4 (WRU), 50 #g per ml of C'2, 
and 500 #g per ml of C'3  (WRU).  Controls lacking CPl esterase, C'4, C'2, or 
C~3, designated  1C,  4C,  2C,  and 3C  respectively, were also  prepared at  the 
same final concentrations of those components present. As described in a later 
section, these concentrations were in considerable excess over those required 
to generate measurable biological activity. 
As shown in Fig.  1, a  single segment of guinea pig ileum, which responded 
well to 0.05 #g of histamine, failed to respond to additions of 0.05 ml of each 
control mixture which lacked one of the four components employed. However, 
addition of 0.05 ml of the complete reaction mixture (HA) resulted in full con- 
traction of the ileum segment with  almost no lag period. A  second addition 
of 0.05 ml of HA produced only a small contraction after a slightly longer lag 
period. A  third addition of 0.05 ml of HA was completely without effect, al- 
though the ileum was still fully responsive to 0.05 gg of histamine. 
Desensitization of guinea pig ileum (tachyphylaxis) with successive additions 
of the same sample is a  salient  characteristic of anaphylatoxin which serves 
to  distinguish  it  from many other  activities  capable  of contracting  smooth 
muscle. The number of applications required to achieve full desensitization and 
the amplitude  of each contraction depend on a  variety of factors, including 
the sensitivity of the ileum segment, the potency of the preparation, and the 
dose employed. The number of contractions observed with different prepara- 
tion  of HA has varied in our experience between one and four. 
The possibility was considered that the manner of testing of samples depicted 
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activity in one or more controls and depressed the activity observed with the 
complete mixture. For example, the control lacking C'I might have been un- 
able to cause  a contraction but might still have effected desensitization to a 
small amount of activity possibly present in the control lacking C'4. The final 
reactivity to the complete mixture under these circumstances might therefore 
also have been speciously low due to prior partial desensitization of the ileum. 
Accordingly, experiments with comparable mixtures were performed in which 
FIG. 1. Effect of mixtures of C'I esterase, C'4, C'2, and C'3, and controls lacking one of 
these components, on contraction of guinea pig ileum in vitro. H  =  0.05 #g histamine base; 
1C, 2C,  3C, and 4C  =  0.05 ml of controls lacking C'I esterase, C'2, C'3, C'4, respectively; 
HA =  0.05  ml of complete mixture. 
each sample was tested on a fresh segment of ileum. The absence of detectable 
activity in each  control mixture and  the unaltered  activity of the  complete 
mixture effectively ruled  out  the  applicability of these  speculations  in most 
of the experiments reported. 
These  experiments  clearly demonstrated  that  a  property  capable  of con- 
tracting guinea pig ileum and  resembling anaphylatoxin in its  desensitizing 
characteristics could be generated from incubation mixtures of C'I  esterase, 
C'4, C'2, and C'3. The requirement for all four reactants was indicated by the 
absence of biological activity in each of the four controls lacking a single com- 
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Effect of Addition of C'5 to Mixtures  of C'1  esterase,  C'4, C'2, and C'3.--The 
effect of C~5 was tested directly by preparing reaction mixtures of C'I esterase 
(2.5 units per ml), C'4 (M-E, 20 #g per ml), C'2 (50/~g per ml), and C'3 (M-E, 
200 #g per ml) similar to those described in the preceding section but contain- 
ing in addition 11,  22, 45, and 113/~g per ml of purified C'5. All of these sam- 
ples  were  equally active on  guinea  pig ileum  and  could  not  be  distinguished 
from a  comparable mixture lacking added C'5. This conclusion was based both 
on  the  amplitude  of contraction  achieved  with  several doses  of  each  sample 
and on the number of additions required to achieve desensitization at a  given 
FIG. 2. Effect of triprolidine on the ability of mixtures  of C'I esterase,  C'4, C'2, and  C'3 
(HA) to contract guinea pig ileum in vitro. H  =  0.05 #g histamine base; B  =  0.05 #g brady- 
kinin;  0.1 HA and 0.2 HA =  0.1 ml and 0.2 ml of complete reaction mixture; T  =  0.05 #g 
of triprolidine; W  =  wash  artifact due to movement  of lever  during  changing  of Tyrode's 
solution in the organ bath. Two different segments of ileum are represented.  On the left, the 
response of untreated ileum to H, B, and HA are shown. The blocking effect of triprolidine on 
the activity of H and HA but not of B and the gradual recovery of reactivity to H are shown 
on the right. 
dose. It appeared therefore that purified C'5 neither augmented  nor inhibited 
the smooth muscle-contracting activity generated from the preparations of C'I 
esterase, C'4, C'2, and C'3 used in these studies. 
Effect  of an Antihistamine  (Triprolidine)  on  the  Smooth Muscle-Contracting 
Activity Generated from Mixtures  of C1 esterase, C'4, C'2, and C'3.--A  reaction 
mixture containing 2 units per ml of Cq  esterase, 20 #g per ml of C'4  (M-E), 
40 vg per ml of C'2,  and  200  #g per ml of C'3  (M-E)  was  incubated at 37°C 
for  5  min  and  chilled in  ice,  as  described previously. After establishing that 
0.1 ml of the final mixture (HA) caused full contraction of a  segment of guinea 
pig ileum, the effect of an antihistaminic drug was  tested  (Fig. 2). 
A  fresh  segment  of ileum from  the  same guinea  pig was  shown  to  respond 
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ileum was then exposed to 0.05/~g of triprolidine for 30 sec. The antihistaminic 
effect of this treatment was demonstrated by failure of the ileum to respond 
to 0.05 #g of histamine without impairment of the response to 0.05 #g of brady- 
kinin. Addition at this point of 0.2 ml of HA, twice the dose previously shown 
to be fully active, failed to cause contraction. Gradual recovery of the ileum 
segment was shown by increasing response to 0.05 #g of histamine at 15 and 
30 rain after application of triprolidine, indicating the reversibility of the anti- 
histaminic effect of this drug and the integrity of the ileum. As a  final check 
on the responsiveness of the untreated ileum to HA, another segment from the 
same gfinea pig was found to contract upon addition of 0.1 ml of HA. 
In  separate  experiments,  the  possibility was  excluded that  the  failure of 
triprolidine-treated ileum to respond to HA was due to inherent nonreactivity 
of that particular segment.  For this purpose,  a  preparation of HA was em- 
ployed which caused a  strong contraction after a  second application.  After 
demonstrating nonresponsiveness of the triprolidine-treated ileum to histamine 
and a  single dose of HA, a  recovery period of about 30 rain was allowed to 
elapse. It was found that when response to 0.05 #g of histamine reappeared, a 
second addition of HA then caused muscle contraction. 
These experiments demonstrated that the activity generated from mixtures 
of C'I esterase, C'4, C'2, and CI3 further resembled anaphylatoxin by virtue 
of inhibition of contraction of guinea pig ileum by an antihistamine. 
Failure of Mixtures of C'1 esterase, C'4, C'2, and C'3 to Contract Rat Uterus. 
--A reaction mixture containing 5 units per ml of C'1 esterase, 50 #g per ml 
of Ct4 (WRU),  50 tzg per ml of C'2, and 500 #g per ml of C'3  (WRU)  was 
incubated at 37°C for 5 rain, chilled in ice, and brought to pH 3.7 with pH 3.0 
glycine buffer. In tests on guinea pig ileum, 0.05 ml of this sample (HA) caused 
full contraction and three applications at this dose were required for complete 
desensitization. The same mixture was then tested on uterine horn from a rat 
in early estrus. The responsiveness of this muscle preparation to 1 ng of brady- 
kinin was first established and 0.1 ml of HA was then applied. No contraction 
was observed, although the horn was still reactive to a  second dose of 1 ng of 
bradykinin. 
Summary of Component Requirements for Generation of Smootk Muscle--Con- 
tracting  Activity  and  Its Anapkylatoxin-Like  Properties.--These  experiments 
demonstrated that an activity capable of contracting guinea pig ileum could 
be generated from reaction mixtures containing Crl esterase, Ct4, C'2, and C13 
and that the presence of all four of these components was required. The further 
addition of C'5 was without potentiating or inhibitory effect on the system, 
suggesting that obligatory component requirements were met at the C'3 step. 
The ability of the activity generated to contract and desensitize guinea pig 
ileum, the blocking effect of an antihistamine, and the failure to contract rat 930  COMPLEMENT  AS  A  MEDIATOR  OF  INFLAMMATION.  II 
uterus were compatible with tentative identification of the activity as anaphyla- 
toxin. 
Some Parameters Affecting the Generation of a Smooth Muscle~7ontracting 
Activity from Mixtures of Purified C'I esterase,  C'4, C'2, and C'3 
Before  proceeding  with  further  biological  characterization  of  the  activity 
described in the previous section, a  few immediately pertinent parameters of 
the  reaction mixture  of purified  components were investigated.  The purpose 
of these experiments was limited to providing assurance that adequate condi- 
tions were being employed for generation of biological activity. In all of the 
studies in this section, the biological reference was contraction and desensitiza- 
TABLE I 
Approximate Concentrations of C'1 esterase, Ct4, C'2, amt C'3 Required/or Minimal 






Concentration for ileum contraction* 
Minimal 
O. 05 unit per ml 
10 gg per ml 
10  "  "  " 
60  "  "  " 
Maximal 
1.0 unit per ml 
25 #g per ml 
25  "  "  " 
200 "  "  " 
* Various concentrations of each component were incubated with adequate or excess con- 
centrations of the remaining three components; 0.1  ml of reaction mixture was applied  to 
different segments of guinea pig ileum. 
tion of guinea pig ileum.  More extensive experiments,  bearing more directly 
on the mechanism of the reaction, will be reported separately. 
Effect of Concentration of Reactants.--A  series of experiments was performed 
in which a range of concentrations of a single component were mixed with the 
remaining three components at concentrations  which appeared to be optimal 
or in excess. Incubations were at 37°C  for various periods of time from 5  to 
30 rain. The mixtures were tested on guinea pig ileum at a  dose of 0.1  ml and 
the  results  recorded  as  the  minimum concentration  of the  component being 
titrated which was required for minimal and maximal contraction under these 
conditions (Table I).  For example, in  the  titration  of C'2,  concentrations  of 
C'2 varying between 5  and  100 #g per ml were incubated at 37°C  for 5 min 
with 2.5  units per ml of C'I esterase, 25 #g per ml of C'4 (M-E), and 200 #g 
per ml of C'3 (M-E). The threshold concentration of C'2 required for minimal 
contraction of ileum was 10 #g per ml, while full contraction at the dose applied 
was observed with 25 ~g per ml. However, higher  concentrations  of reactants 
gave mixtures  of still  greater  potency,  as  evidenced  by lower  dose  require- W.  DIAS  DA  SILVA  AND  IRWIN  H.  LEPOW  931 
ments for ileum contraction and the number of doses required to desensitize. 
For this reason, multiples of the concentrations shown in Table I  were usually 
employed. 
The results in Table I  were interpreted only as a  qualitative  indication of 
the concentrations of particular preparations of reactants giving adequate bio- 
logical  activity.  The  difficulties  of  quantifying  the  system further  are  com- 
pounded  not  only by the  possibility that  different concentrations  of a  given 
reactant might influence  the  threshold  concentration  of another but  also by 
the inherent limitations of a biological assay which requires testing on separate 
segments of ileum which may vary significantly in reactivity. However, these 
experiments provided a guide for further studies. They also gave an indication 
TABLE II 
Effect of Sodium and Magnesium Salts of EDTA on the Generation of Smooth Muscle-- 
Contracting Activity from Mixtures of C'I Esterase, C'4, C'2  and C'3 




Contraction  of guinea pig ileum 
First dose  Second dose 
87  8 
0  0 
94  4 





* Designates extent  of immunoelectrophorefic conversion of C'3 from the  native  form 
which migrates cathodically to anodically faster species; 4+ refers to complete conversion. 
:l: Sample tested on same segment of ileum which failed to respond to sample containing 
Na~HEDTA. 
§ Sample tested on fresh segment of ileum from same guinea pig. 
that the required concentrations of reactants were physiologically realistic. The 
concentrations  of C'2,  CP3, and C'4 giving maximal activity in Table I  were 
roughly comparable to normal serum concentrations which have been estimated 
for these components and the amount of C'I esterase was far less than that 
which is potentially available in normal serum. It should be emphasized that 
the final concentrations of reactants in the ileum assay were actually only one- 
fiftieth of those shown, since 0.1  ml of sample was added to a 5 ml organ bath. 
Requirement fo~ Mg~+.--The effect of chelation  of divalent  cations  on  the 
generation  of smooth  muscle-contracting  activity from mixtures  of purified 
components of complement was studied employing the sodium and magnesium 
salts of EDTA. Reaction mixtures consisting of 5 units per ml of Cq esterase, 
50 #g per ml of C'4 (WRU),  50 #g per ml of C~2, and 500 #g per ml of C'3 
(WRU)  were incubated at 37°C  for 5 rain in the  absence of EDTA or in the 
presence of either  5  X  10  -~ ~r NaJ-IEDTA or Na2MgEDTA.  The  resulting 
samples were tested on guinea pig ileum at a dose of 0.1  ml.  As shown in Table 932  COMPLEMENT  AS A  MEDIATOR  OF INFLAMMATION.  II 
II, Na~r-IEDTA completely inhibited the generation of biological activity from 
this mixture, while Na2MgEDTA was without effect as compared with the con- 
trol. The presence of Na3HEDTA also blocked the immunoelectrophoretic con- 
version of C'3 to anodically faster components, as presented in a later section. 
These results,  compatible with  a  requirement for Mg  2+  but not  Ca  w  in  the 
reaction mechanism, provided the basis for routine incorporation of Mg  ~+ into 
the buffer used as diluent in all reaction mixtures (PBS-Mg~+). 
Effect of Time of Incubation at 37°C.--In this experiment, all reactants were 
mixed at 0°C to give final concentrations of 5 units per ml of C'I esterase, 50 
#g per ml of C'4 (WRU), 50 #g per ml of C'2, and 500 #g per ml of C'3 (WRU). 
Zero time was noted as the time of addition of C'I esterase to the remaining 
reactants.  The mixture was placed immediately in a  37°C water bath.  Sam- 
ples  of 0.18 ml were withdrawn into 0.02 ml of 0.05 M Nag{EDTA  at 0.5, 
2, 5, 15, and 30 rain, chilled in ice, and tested as soon as possible on guinea pig 
ileum at a  dose of 0.05 ml. A  comparable control was included in which C'I 
esterase was omitted. 
All samples removed from the tube containing the complete reaction mixture 
were flflly active on guinea pig ileum and no activity was observed in any of 
the control samples.  Thus, under the conditions employed, the generation of 
a  smooth muscle-contracting property from Ctl  esterase,  Cr4,  C'2,  and  C'3 
occurred  within  30  sec  at  37°C  and  was  not  adversely affected by  incu- 
bation for  30  rain.  These  results  provided  assurance  of  the  adequacy  of 
incubation times of 5-30 min. It was recognized that a time curve might have 
been demonstrated at  lower concentrations of reactants and at a  lower test 
dose on guinea pig ileum but such experiments were not germane to our pur- 
pose at this time. 
Immunoelectrophoretic Analysis  (IEP) of Reaction Mixtures.--An  excellent 
correlation was observed between the generation of smooth muscle--contract- 
ing activity from mixtures of purified components and the conversion of C~3 to 
antigenically related but anodically faster migrating species in IEP. Reaction 
mixtures to be tested in IEP were not acidified because of alterations in the 
immunological behavior of Ct3. Controls lacking a single component and devoid 
of biological activity all showed a pattern in IEP identical to that of C'3 alone. 
In the presence of adequate concentrations of C'I esterase, Ct4 and Ct2,  C'3 
was fully converted to a  major very fast component and a  minor component 
in the area of the antigen well, both of which reacted with antiserum prepared 
against  purified C'3  or whole human  serum.  In all such  cases,  the mixtures 
were capable of contracting guinea pig ileum. 
A representative experiment is shown in Fig. 3. Although in this instance the 
bottom well contained a  control lacking only Cq  esterase,  the  same results 
were obtained with controls lacking only C'2  or C'4 or with  C'3  itself. The W.  DIAS  DA  SILVA  AND  IRWIN  H.  LEPOW  933 
top well,  containing all four reactants incubated at 37°C  for 5  min,  appeared 
exactly the  same when  the mixture was  tested after incubation for periods of 
0.5-30  min,  as  described in  the  previous  section.  For  this  purpose,  the  agar 
used for IEP  contained 5  X  10  --8 •  Na3HEDTA  in an attempt  to inhibit fur- 
ther  conversion during electrophoresis. 
On occasion and usually associated with waning activity of components,  the 
FIG. 3. Immunoelectrophoretic analysis of mixtures of purified components  of complement 
incubated at 37°C for 5 rain.  Bottom well: C'4 (WRU, 50 #g per ml), C'2  (50 #g per ml), 
and C'3 (WRU, 500 #g per ml). Top well: same concentrations  of reactants as in bottom well 
but also containing  5 units per ml of C'I esterase. The trough contained rabbit antiserum to 
purified human C'3. Anode is at the left. 
FIo. 4. Immunoelectrophoretic analysis of mixtures of purified components  of complement 
incubated at 37°C for 5 rain. Top well: Ctl esterase  (2.5 units per ml), C'2 (30 #g per ml), 
C'3 (WRU, 200 #g per ml); middle well: same concentrations of reactants as in top well but 
also containing C'4 (WRU, 25/zg per ml); bottom well: C'3 alone  (WRU,  200 #g per ml). 
The troughs contained  rabbit antiserum to whole human serum.  Anode is at the left.  The 
biological activity of the complete mixture in the middle well was less than that of the corre- 
sponding mixture in Fig. 3. 
pattern  shown  in  the  middle well of  Fig. 4  was  observed.  This  demonstrates 
residual  unconverted  C'3,  as  well as  two  faster  protein  species,  all of  which 
are antigenically closely related. In such cases, the middle arc near the antigen 
well was  considerably more  dense  and  distinct than  shown  in  Fig. 3.  Incom- 
plete  conversion  of  C'3  was  associated  with  less  smooth  muscle-contracting 
activity than  that  obtained  with  full  conversion.  In  separate  experiments  in 
which  the concentration of C4  was known  to be limiting and  only very weak 
biological activity was  obtained, the pattern  of the middle well of Fig. 4  was 
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Other Biological Properties of Mixtures of Purified C'1 Esterase, 
C4,  C'2, and C'3 
Enhancement  of  Vascular  Permeability  in  Guinea  Pig  Skin.--The  activity 
of mixtures  of purified  C'I  esterase,  C'4,  C'2,  and  C'3  and  controls  lacking 
single components was tested for enhancement of vascular permeability in the 
skin of guinea pigs previously untreated or injected intravenously with an anti- 
histaminic  drug  (triprolidine)  (18).  In  view  of  the  permeability  enhancing 
property of higher concentrations of C'I esterase alone (2), mixtures were made 
TABLE III 
Effect of Mixtures  of Purified  C'I Esterase, C'4, C'2, and C'3 and Control Mixtures Lacking 
Individual  Components on Vascular Permeability in Guinea Pig Skin in the Presence 
and Absence of Triprolidine 
Components in mixture 
C'2, C'3, C'4 
C'I esterase, C'4, C'3 
"  "  C'2, C'3 
"  "  C'4, C'2 




Histamine (50 #g per ml) 
Bradykinin (10/zg per ml) 
PBS-Mg  s÷ 



























at 37°C  for 5 rain with only 2 units  per ml of this enzyme. C'4 (WRU)  was 
used at a concentration of 50 #g per ml; a  very highly purified preparation of 
C'2 was used at I0/zg per ml; and C'3 (WRU) was used at 500 #g per ml. The 
complete mixture  (HA)  was active on guinea pig ileum,  three applications of 
0.05 ml being required for full desensitization. When the complete mixture was 
diluted  1/2,  two applications of 0.05  ml desensitized the ileum; when diluted 
1/4~ a single application gave only partial contraction. All of the controls were 
inactive on ileum. 
Samples (0.1  ml)  were then injected intradermally into  two groups of four 
guinea  pigs,  one  of which  received only Pontamine  Sky Blue  intravenously 
while  the  other was given triprolidine  (0.1  mg per kg)  with  the  dye.  In the W.  DIAS  DA  SILVA  AND  IRWIN  H.  LEPOW  935 
absence of triprolidine, the results  (Table III) showed highly significant en- 
hancement of vascular permeability by undiluted HA, an effect which dimin- 
ished toward control values with further dilution. Controls lacking C'1,  C'3, 
and C'4 induced permeability of vessels  only slightly greater than the diluent 
(PBS-Mg  ~+) itself. However, the control lacking C'2 was as active as the com- 
plete mixture (HA). In the presence of triprolidine, the permeability enhancing 
activity of HA and the control lacking C'2 was entirely inhibited. 
This experiment, representative of several others, demonstrated a correlation 
between the ability of mixtures of C'1 esterase, C'4, C'2, and Ct3 to contract 
guinea pig ileum and to enhance vascular permeability in guinea pig skin. There 
TABLE IV 
Effect of Mixtures of Purified C'1 Esterase, C'4, C'2, and C'3 and Control Mixtures Lacking 
Individual  Components on Reduction of Metachromatically Staining  Mast Cells in 
Guinea Pig Mesentery Preparations 
Components in mixture 
C'2, C'3, C'4 
C'I esterase, C'4, C'3 
"  "  C'2,  C'3 
"  "  C'4,  C'2 
C'I esterase, C'4, C'2, C'3 (HA) 
Rat plasma -{- agar* 
Contraction of 








Reduction of mast 
cells  in  guinea 








* Rat plasma containing  NaslVIg EDTA was incubated at 37°C for 30 min with 100 /~g 
per ml of agar suspension. 
was a  further correlation in the blocking effect of triprolidine in both assay 
systems. An  apparent  discrepancy existed,  however,  in  the  lack of smooth 
muscle activity of mixtures of C'I esterase, C'3, and C'4 and the presence of 
permeability enhancing activity in the same mixture. Since the latter property 
was not demonstrable in triprolidine-treated guinea pigs,  it may be assumed 
that the activity measured, in common with anaphylatoxin, acted by way of 
histamine release. It has tentatively been concluded that these results are ref- 
erable  to  the  presence of guinea pig C'2 at the injection site, constituting a 
a  complete system for generation of anaphylatoxin in vivo. The  absence of 
activity in other controls is more readily interpretable, since mixtures lacking 
C'I esterase do not have a source of active C'I and mixtures lacking C'4 and 
C'3 have decayed or ineffective CP2 prior to injection. Experiments bearing on 
these interpretations will be presented separately. 
Effect on Mast Cells in Guinea Pig Mesentery Preparations.--Mixtures of C'I 
esterase (5 units per ml), C'4 (WRU, 50 #g per ml), C'2 (75 #g per ml), and C'3 936  COMPLEMENT  AS A  MEDIATOR  OF INFLAMMATION.  II 
(WRU, 500/~g per ml), incubated at 37°C for 5 min, were found to be capable 
of reducing the number of metachromatically staining mast cells in fragments 
of guinea pig mesentery. In the experiment shown in Table IV, there was an 
excellent correlation between the lack of activity on guinea pig ileum (0.05  ml) 
or mesentery (0.7  ml) of controls lacking individual components and the pres- 
ence of both of these activities in the complete mixture of four components or 
in rat anaphylatoxin generated with agar. In addition to the recorded reduction 
of stainable  mast cells with  both  of the  latter  preparations,  there  were also 
characteristic  morphological  alterations  of many  of  the  cells  which  stained 
TABLE V 
Effect of Mixtures of Purified  C'I Esteroae, C'4, C'2, and C'3 and Control Mixtures Lacking 
Individual Components on Rdeoae of Histamine from Isolated Rat Peritoneal Moat Cdls 
Contraction  IEP conversion  Histamine  release  Components  in mixture  of guinea  from rat peritoneal  pig ileum  of C'3"  mast cetls~/ 
C'2, C'3, C'4 
C'I esterase, C'4, C'3 
"  "  C'2, C'3 
"  "  C'4, C'2 
C'I esterase, C'4, C'2, C'3 (HA) 


















* Designates extent  of immunoelectrophoretic convermon of C'3 from the  native  form 
which migrates cathodically to anodically faster species; 4+ refers to complete conversion. 
Data for 0.8 ml of each mixture in a final reaction volume of 1.0 ml; average of experi- 
ments with two different pools of peritoneal cell suspensions each from three rats. 
metachromatically with toluidine blue. These were similar to those previously 
described by Mota (22) for anaphylatoxin. 
Although  not  an isolated  observation,  the  data  of Table IV are not fully 
representative of all experiments of this kind which have been performed. In 
all cases, the controls lacking individual components were inactive. However, 
the extent of activity observed with rat anaphylatoxin and the complete mix- 
ture of C'1 esterase, C'4, C'2, and C'3 (HA) was variable and not necessarily 
internally correlated.  Thus,  in one experiment, HA showed good activity  on 
mesentery while rat anaphylatoxin was only marginally active; in another,  HA 
appeared inactive and rat anaphylatoxin was highly active. The basis for this 
variability is not known. The empirical difficulties of this system led to direct 
experiments with isolated mast cells. 
Effect on Isolated  Rat Peritoneal Mast Cell Preparations.--Mixtures of C'I es- 
terase (5 units per ml), C'4 (WRU, 50 #g per ml), C'2 (50 #g per ml), and C'3 W. DIAS DA SILVA AND  IRWIN H, LEPOW  937 
(WRU, 500/~g per ml), incubated at 37°C for 5 min,  were highly active in re- 
leasing histamine from isolated rat peritoneal mast cell suspensions  (Table V). 
The complete mixture (HA) also demonstrated full conversion of C'3 in immuno- 
electrophoretic analysis (IEP) and activity on guinea pig ileum (0.05 ml). Con- 























0-CELL  POOL  A 
A-CELL  POOL  B 
I  I  I  I 
0  0.1  0.5  0.5  0.8 
HA  (rnl) 
F1o. 5. ITast~mine release  from isolated  rat peritoneal  mast cell  suspensions by mixtures of 
C'I esterase,  C~4, C'2, and Ct3 (HA); effect  of concentration of HA  on two different  pools of 
cells. 
histamine from rat peritoneal cells or contracting guinea pig ileum and showed 
no conversion of C'3 in IEP. However, in this experiment, the control lacking 
C'4 had minimal activity in the histamine and ileum assays and further showed 
minimally observable conversion of C'3. There was therefore an excellent  cor- 
relation in these three independent systems. The explanation for the presence 
of detectable activities in the control lacking C'4 is not known with certainty 
but may be related to the presence of small amounts of C'4 or C'4-C'2 complex 
in this preparation of C'2, not detectable by antigenic analysis. 
The effect of various concentrations of HA on histamine  release  from two 938  COIVIPLEM~ENT  AS  A  MEDIATOR  OF  INFLAMMATION.  II 
different pools of rat peritoneal mast cells is depicted in Fig. 5. The linearity 
of the dose-response curve and the quantitative  variability of cell suspensions 
are demonstrated. 
Cross-Desensitization  of Guinea Pig  Ileum  by Anaphylatoxins  of  Different 
Species.--All  of the  experiments  reported  on the  biological properties  of the 
TABLE VI 
Cross-Desensitizing Properties of Human,  Rat,  and Guinea Pig Anaphylatoxins  Prepared by 
Various Procedures: Guinea Pig Ileum Assay 
Ileum desensitized with  Ileum challenged with 
Result of challenge 
Anaphylatoxin  Species  Anaphylatoxin 







Plasma +  agar 






Plasma +  agar 
Purified compo- 
nents 
Plasma +  agar 











Plasma +  agar 




Plasma -1- agar 







* Ileum failed  to contract following indicated  challenge but then responded  to human 
anaphylatoxin  prepared  with purified components of complement. 
~; Ileum contracted  following indicated challenge but was desensitized following only two 
applications of rat anaphylatoxin,  as compared with five applications when a fresh segment 
of ileum was employed. Complete desensitization to both guinea pig and rat anaphylatoxins 
did not prevent contraction  upon addition  of human anaphylatoxin  prepared  with purified 
components  of complement. 
activity generated from mixtures of purified human C'I esterase,  Cr4, C'2, and 
C'3 were  compatible  with identification  of this  activity as anaphylatoxin.  It 
was therefore of interest  to gain preliminary insight into the mutual identity 
of anaphylatoxins prepared with plasma or plasma proteins of different species, 
using  desensitization  and  cross-desensitization  of guinea pig  ileum  as  a  con- 
venient criterion. For this purpose, rat anaphylatoxin was prepared by incuba- 
tion of rat plasma with agar or human C'I esterase  (1); guinea pig anaphyla- 
toxin by incubation of guinea pig plasma with agar; and human anaphylatoxin W.  DIAS  DA  SI"I".VA AND  IRW~]"  H.  LEPOW  939 
by incubation of purified human Ctl esterase, C'4, Cr2, and Ct3, as described 
in previous sections. 
In all cases,  a  segment of guinea pig ileum was completely desensitized by 
repetitive additions of anaphylatoxin from one species and then challenged with 
anaphylatoxin of another species.  If the challenge dose elicited contraction of 
the previously densensitized ileum, it was concluded that anaphylatoxin of the 
first species  did not cross-desensitize to the second species.  Similarly, if the 
challenge dose failed to elicit a contraction, the result was interpreted as cross- 
desensitization between the two species.  Finally, ff the challenge dose elicited 
contraction of the previously desensitized ileum but many fewer applications of 
the challenge anaphylatoxin were required for subsequent desensitization, as 
compared with results on a  fresh segment of ileum, partial cross-desensitiza- 
tion between the two species was indicated. 
The results of this series  of experiments, summarized in Table VI, showed 
that rat anaphylatoxin failed to cross-desensitize to human anaphylatoxin and 
vice versa; that guinea pig anaphylatoxin failed to cross-desensitize to human 
anaphylatoxin and  vice  versa;  that  rat  anaphylatoxin fully desensitized  to 
guinea pig anaphylatoxin; and that guinea pig anaphylatoxin partially desen- 
sitized to rat anaphylatoxin. It was clear from these data that anaphylatoxin 
generated from purified components of human complement could be  differ- 
entiated on the basis of this biological parameter from rat or guinea pig ana- 
phylatoxin but that a  closer biological relationship existed between rat  and 
guinea pig anaphylatoxins. 
DISCUSSION 
Friedberger (23) introduced the term "anaphylatoxin" to designate a prop- 
erty that induced a syndrome similar to anaphylactic shock in guinea pigs when 
homologous serum was exposed to immune precipitates. A similar activity was 
also produced with certain polysaccharides, such as agar (24, 25), starch (26), 
or inulin (27).  These observations were later extended to serum from other 
animal species,  including rabbit and rat (28). A renewed interest in the mecha- 
nism of anaphylatoxin formation and the nature of anaphylatoxin itself was 
initiated  by observations that its effects on the whole animal or on isolated 
smooth muscle  (29)  could, at least in part,  be explained on the basis of its 
histamine-releasing properties (22, 30, 31). 
Friedberger's hypothesis (32) that the complement system might be involved 
in anaphylatoxin formation was revived in the last decade (33, 34).  In an ex- 
perimental approach  to this concept using immune aggregates and fresh rat 
serum, Osler and coworkers (35)  found a  direct relationship between loss in 
hemolytic activity of the serum, loss in activity of C~3 components, and gen- 
eration  of an activity which enhanced vascular permeability and contracted 
smooth muscle. However, more rigorous definition of the role of complement 940  COMPLEMENT  AS  A  MEDIATOR  O~'  INFLAMMATION,  II 
and the nature of anaphylatoxin  itself  awaited purification,  characterization~ 
and elucidation of the mechanism of action of complement components. 
Studies on the mechanism of anaphylatoxin  formation  employing purified 
components of complement were initiated in this laboratory by examining  the 
effects of highly  purified  C'I  esterase  in  inducing  enhancement  of vascular 
permeability in guinea pig skin or in generating an activity indistinguishable 
from anaphylatoxin  when incubated with rat or guinea pig serum  (1-3).  On 
the basis of these experiments,  it was postulated that anaphylatoxin might  be 
a product of interaction of C'I esterase,  C'4, C~2, Cr3, and perhaps later acting 
components. With this information at hand and with the availability of tech- 
niques for preparing highly purified components, a direct attack on the problem 
became possible. 
In  the  present  report,  we  have  indeed  demonstrated  that  interaction  of 
highly purified  preparations of human Cq esterase, C~4, C~2, and C~3 in the 
presence of Mg  ~  results in generation  of an activity which,  in its range  of 
biological properties, is identifiable  as anaphylatoxin.  These biological effects 
include  contraction and desensitization of guinea pig ileum, failure  to contract 
rat uterus, enhancement of vascular permeability in guinea pig skin,  degranu- 
lation of mast cells in guinea pig mesentery preparations,  and release  of his- 
tamlne from rat peritoneal mast cell suspensions. The histamine-releasing  prop- 
erty was further emphasized by the blocking  effect of an antihistaminic  drug, 
triprolidine,  on contraction of guinea pig ileum and enhancement of vascular 
permeability. 
The requirement for antigen-antibody complexes  or other inducers of ana- 
phylatoxin formation was bypassed in our experiments by constructing a free 
solution system in which Cq esterase was used as the initiator of subsequent 
reactions of the complement sequence.  The primary function of the immune 
complex in the complement system is to combine with CPl in a reaction which 
results in creation of a catalytic center on the Cqs portion of the macromolec- 
ular complex of Cqq-Cqr-Cqs (11, 36). Although the intact activated complex 
of Cq is the functional unit in immune hemolysis (36, 37), the enzymatically 
active subunit derived from Cqs, designated Cq esterase, is capable of reacting 
in  free  solution  with  subsequently acting  components.  Such  reactions  may 
either be observed as inactivation  of the hemolytic activity of C~4 and  C~2 
(37, 38) or as transient activation of a component, as in formation of the arti- 
ficial intermediate complex,  ECt4,  by incubation of unsensitized erythrocytes 
with purified  human Cq esterase and C'4 (39). Thus, the use of C'I esterase 
permitted examination of reaction mixtures composed entirely of solutions of 
complement components, uncomplicated by the presence of additional reactants 
or an insoluble phase. 
Reaction mixtures composed of Cq  esterase, C~4, C'2,  C'3, and Mg  ~+ and 
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for generation of anaphylatoxin.  The concentrations of these components re- 
quired for evolution of measurable biological activity were within physiological 
limits. Addition of pure CP5 neither enhanced nor inhibited the system, strongly 
suggesting that only the first four components of complement are necessary for 
anaphylatoxin formation. The present data do not permit this conclusion to be 
drawn with absolute assurance since  other activities, not measurable by cur- 
rent methods,  could conceivably have been involved. However, independent 
data will be reported separately which  clearly indicate that anaphylatoxin is 
a  relatively low molecular weight split product of C'3, confirming  the present 
findings  that only the complement sequence as far as C'3 is necessary and as- 
signing a causal relationship to immunoelectrophoretic conversion of C'3 (Figs. 
3  and  4) and  generation  of anaphylatoxin.  These experiments  are based on 
separation of labeled anaphylatoxin from mixtures of C'1  esterase,  C'4,  C'2, 
and physicochemically and immunochemically pure 131I- or 1=I-labeled C'3. They 
are conceptually in accord with a report that rat and pig anaphylatoxins,  in- 
duced by the action of cobra venom on the respective plasmas, are split products 
of a plasma protein (40). 
An apparent discrepancy exists, however, between these findings and the ob- 
servations reported  by Jensen  (41) from Nelson's laboratory that  anaphyla- 
toxin is derived from guinea pig C'3b. This conclusion is based on studies with 
a  purified  cobra venom factor,  antigen-antibody  complexes,  or  trypsin  and 
"functionally purified" components of guinea pig complement. In the nomen- 
clature used by Nelson for guinea pig components, C'3b appears to correspond 
to human C'5. The explanation for the difference in Jensen's conclusions  and 
our own is not fully available at this time.  Factors to be considered  and in- 
vestigated include possible differences of pathways with guinea pig and human 
components in terms of intrinsic species variations.  The possibility must  also 
be entertained that undetected activities or inhibitors may be present in either 
Nelson's preparations  of complement components or our own.  For example, 
preparations of pure C~4 which have lost hemolytic activity during  storage at 
2°C continue, for a further period, to retain the ability to participate in  ana- 
phylatoxin formation with C'1  esterase,  C'2,  C'3, and Mg  ~+ in free solution. 
Thus, complete reliance  on hemolytic activity may not be adequate for func- 
tional  characterization  of a  purified  component of complement. In addition, 
since the full range of biological properties of Jensen's activity has not yet been 
reported, the further possibility is admissable that  C'3b may serve as a  sub- 
strate from which a biologically active factor may be generated which is similar 
to but distinct from that described in this paper. 
The ability of the activity generated from purified  components of comple- 
ment to liberate histamine from suspensions  of rat peritoneal mast cells repre- 
sents, to our knowledge,  the first description of this property of anaphylatoxin. 
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release from mast cells, described by Austen and Becker (42), might be mediated 
by anaphylatoxin. Indeed, some of the experiments described in the present 
paper were being conducted at the same time as those reported by Austen and 
Becker and the parallelism between the two systems in the requirement for 
C'I, C'4, C'2, and C'3 was striking. Apparent d/ssociation of the two mecha- 
nisms emerged,  however,  when a  requirement  for  C'5  was  demonstrated in 
Austen and Becker's experiments but not our own. The data now available 
would  suggest  that  complement-dependent,  noncytotoxic histamine  release 
from mast cells proceeds by a mechanism distinct from that operative in hista- 
mine release from mast cells by anaphylatoxin. However, direct investigation 
of the possible role of anaphylatoxin in the former system appears indicated. 
The possible relationship of anaphylatoxin generated from mixtures of human 
C'I esterase, Ct4, C'2, Ct3, and Mg  ~+ to two other split products of C'3 which 
have recently been encountered must also be considered. These studies further 
serve  to  emphasize  the  existence of alternate pathways to  the  complement 
system and the potentially important role of products of Ct3 in mediation of 
of events of the acute inflammatory response. Ward  2 has found that incuba- 
tion of plasminogen and streptokinase with pure human C'3 results in cleavage 
of the C"3 molecule with liberation of a  chemotactic fragment of about 6000 
molecular weight. In direct collaborative experiments with Dr. Ward, we have 
found that the plasmin-generated product of C'3 does not contract guinea pig 
ileum and anaphylatoxin is not chemotactic3 It would appear, therefore, that 
plasmin and the earlier acting complement components exert a  different bio- 
chemical attack on C'3 yielding split products which, at least in part,  have 
distinct biological characteristics. 
The  relationship  between  human  anaphylatoxin  and  the  C'3  fragment 
recently described by Miiller-Eberhard (43) has not yet been investigated. Vogt 
and  Schmidt (44)  have reported purification of a  factor from cobra venom, 
free of proteolytic, hemolytic, and phospholipase A activities, which is capable 
of generating anaphylatoxin from rat serum. Mfiller-Eberhard and coworkers 
have now shown that the cobra venom factor (7S) forms a complex (9S)  with 
a serum protein (5S) which then acts on C'3 to yield a split product with bio- 
logical properties not yet fully reported but compatible with possible identity 
or relation to anaphylatoxin. Aside from the nature and species  source of the 
substrate, the cobra venom system under study by Miiller-Eberhard and by 
Jensen (41)  appear  entirely analogous. Direct comparison of the human and 
guinea pig products obtained by these investigators and the human anaphyla- 
toxin reported here is clearly indicated. 
2  Ward, P. A. A plasmin-split  product of C'3 as a new chemotactic  factor. Manuscript in 
preparation. 
3  Ward, P. A., W. Dias da Silva, and I. H. Lepow. Unpublished data. W.  DIAS  DA  SILVA  AND  IRWIN  H.  LEP0W  943 
The experiments on cross-desensitization  of guinea pig ileum by rat, guinea 
pig, and human anaphylatoxins were conducted initially to evaluate the bio- 
logical  relationships  between rat-human and  guinea pig-human  anaphyla- 
toxins.  When no cross-desensitizing  properties were observed between these 
pairs,  it became of interest to investigate the relationship of rat and guinea 
pig  anaphylatoxins. This  was  undertaken because  of previous  experiments 
quoted frequently as evidence against the participation of anaphylatoxin in 
organ anaphylaxis in vitro. Greisman (45) and Mota (22) showed that segments 
of ileum from guinea pigs sensitized in vivo to a given antigen could be made 
unresponsive by repetitive additions of rat anaphylatoxin in vitro  but  could 
nevertheless still contract upon addition of the specific antigen. Assuming that 
the addition of antigen might have initiated liberation of guinea pig anaphyla- 
toxin,  the validity of the interpretation placed on such experiments depends 
on the cross-desensitizing  property of rat and guinea pig anaphylatoxins, a 
property not previously studied. However, we have shown that desensitization 
of guinea pig ileum with rat anaphylatoxin fully cross-desensitizes to guinea 
pig anaphylatoxin, an observation fully supporting the original conclusions (22, 
45). 
It may now be stated with certainty, 56 yr after Friedberger's original dis- 
covery (23), that anaphylatoxin is indeed a product of the complement system. 
The biochemical characterization of its mechanism of generation and the chem- 
ical characterization of the product itself are directly approachable problems 
which have been under study in this laboratory. However, definition  of the 
conditions under which anaphylatoxin may be formed in vivo and evaluation 
of its pathophysiological  importance in the pathogenesis of inflammatory proc- 
esses  mediated by complement are perhaps the more formidable challenges 
for future investigations. 
SUMMARY 
Interaction in free solution of highly purified  preparations of human Crl 
esterase, Cr4, Cr2, and C'3, in the presence of Mg  ~+, resulted in rapid generation 
of an activity indistinguishable  by biological criteria from anaphylatoxin. The 
formation of anaphylatoxin was  associated with immunoelectrophoretic con- 
version of C~3 to anodically faster migrating proteins and was unaffected by 
the presence or absence of added C~5. 
The biological properties of human anaphylatoxin prepared in this manner 
include: contraction and desensitization of isolated guinea pig ileum, failure to 
contract isolated rat uterus, enhancement of vascular permeability in guinea 
pig skin, degranulation of mast cells in guinea pig mesentery preparations, and 
liberation of histamine from suspensions of rat peritoneal mast cells. The smooth 
muscle--contracting  and permeability enhancing properties were fully blocked 
by  an  antihistaminic  drug,  triprolidine.  No  cross-desensitizing  activity on 944  COMPLEMENT  AS  A  MEDIATOR  OF  INFL~ATION.  II 
guinea pig ileum was demonstrable  between rat and human or guinea pig and 
human  anaphylatoxins  but  a  closer  biological  relationship  between  rat  and 
guinea pig anaphylatoxins was observed. 
It is concluded that anaphylatoxin is a  product of the complement system. 
Its  possible  relationship  to  apparently  similar  activities  currently  being  ob- 
tained in other laboratories  has  been discussed. 
The authors gratefully acknowledge generous gifts of pure C'3, C'4, and C'5 and anfisera to 
C'3 and C'5 from Dr. Hans J.  N[tiller-Eberhard. These reagents were invaluable for launch- 
ing  this  investigation  and providing  reference comparison with  preparations  made  in  this 
laboratory.  The technical assistance of Mr. Earl W. Todd is also appreciated. 
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